1 results match your criteria: "Goyang dKonkuk University School of Medicine[Affiliation]"
High-dose atorvastatin for preventing contrast-induced nephropathy in primary percutaneous coronary intervention.
J Cardiovasc Med (Hagerstown)
March 2015
aDivision of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do bDivision of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul cDivision of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Ilsan Paik Hospital, Goyang dKonkuk University School of Medicine, Seoul, Republic of Korea.
Aims: To evaluate the efficacy of high-dose atorvastatin on contrast-induced nephropathy (CIN) occurrence in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
Methods: We studied whether 80 mg atorvastatin loading and its subsequent use for 5 days (high-dose group) could prevent CIN as compared to those who received 10 mg atorvastatin (regular-dose group) in patients with ST-elevation myocardial infarction undergoing primary angioplasty. The primary endpoint was incidence of CIN, defined as an at least 25% or at least 0.